ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Options Flow

Live Options Flow

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P TSX Capped Composite...
35.04
0.60%
US Tech 100
17,446.00
2.17%
S&P 500
5,127.79
1.26%
US Dollar vs CAD
1.36685
-0.02%
Bitcoin
63,878.76
1.57%
Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Processa Pharmaceuticals Inc (PCSA)

  7. Processa Pharmaceuticals Inc (PCSA) News

PCSA Processa Pharmaceuticals Inc

2.14
-0.12 (-5.31%)
May 03 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Stock Type
Processa Pharmaceuticals Inc PCSA NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
Upgrade Icon
-0.12 -5.31% 2.14 19:00:00
Open Price Low Price High Price Close Price Previous Close
2.30 2.15 2.30 2.17 2.26
more quote information »

Recent News

Date Time Source Heading
4/30/202407:00GLOBEProcessa Pharmaceuticals Names Dr. Steven Cha Senior Vice..
4/11/202407:00GLOBEProcessa Pharmaceuticals Presents Two Abstracts at the AACR..
3/28/202407:15GLOBEProcessa Pharmaceuticals to Present at the MedInvest Biotech..
3/25/202407:15GLOBEProcessa Pharmaceuticals to Present Data at the American..
2/21/202416:25EDGAR2Form 8-K - Current report
2/21/202407:15GLOBEProcessa Pharmaceuticals to Present at the 2024 BIO CEO &..
2/14/202412:00GLOBEProcessa Pharmaceuticals to Present at The Winter Wrap-Up..
2/06/202407:30EDGAR2Form 8-K - Current report
2/06/202407:30GLOBEProcessa Pharmaceuticals Regains Compliance with Nasdaq..
2/01/202417:32EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2/01/202415:22GLOBEProcessa Pharmaceuticals Announces Closing of $7.0 Million..
1/31/202415:37EDGAR2Form 4 - Statement of changes in beneficial ownership of..
1/30/202409:46EDGAR2Form 8-K - Current report
1/29/202415:15EDGAR2Form 424B4 - Prospectus [Rule 424(b)(4)]
1/28/202423:15EDGAR2Form EFFECT - Notice of Effectiveness
1/26/202408:04GLOBEProcessa Pharmaceuticals Announces Pricing of $7.0 Million..
1/25/202407:35EDGAR2Form 8-K - Current report
1/25/202407:30GLOBEProcessa Pharmaceuticals Announces Successful Completion of..
1/19/202407:00EDGAR2Form 8-K - Current report
1/19/202406:45GLOBEProcessa Pharmaceuticals Announces Expansion of NGC-Cap..
1/18/202407:30EDGAR2Form 8-K - Current report
1/18/202406:45GLOBEProcessa Pharmaceuticals to Effect a 1-for-20 Reverse Stock..
1/08/202415:30EDGAR2Form 8-K - Current report
1/02/202416:06GLOBEProcessa Pharmaceuticals to Present at the Biotech Showcase..
12/29/202307:55EDGAR2Form S-1 - General form for registration of securities under..
12/19/202308:00EDGAR2Form 8-K - Current report
12/19/202308:00GLOBEProcessa Pharmaceuticals Provides Interim Analysis from..
12/13/202308:00GLOBEProcessa Pharmaceuticals Announces Successful Phase 2..
12/05/202316:18EDGAR2Form 8-K - Current report
11/30/202307:15GLOBEProcessa Pharmaceuticals to Present at the MedInvest..
11/29/202307:15GLOBEProcessa Pharmaceuticals Issues Letter to Shareholders..
11/16/202314:10EDGAR2Form 8-K - Current report
11/15/202310:30EDGAR2Form 8-K - Current report
11/13/202315:00EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
11/13/202313:45EDGAR2Form 8-K - Current report
11/13/202312:40GLOBEProcessa Pharmaceuticals, Inc. Mourns the Sudden Passing of..
11/09/202307:15GLOBEProcessa Pharmaceuticals to Present at the 20th Orphan Drugs..
11/01/202307:15GLOBEProcessa Pharmaceuticals Announces Formation of Oncology..
10/16/202308:15EDGAR2Form 8-K - Current report
10/13/202312:08GLOBEProcessa Pharmaceuticals to Present at the ThinkEquity..
10/12/202317:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/12/202317:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/12/202317:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/12/202316:58EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/10/202316:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/10/202316:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/10/202315:56EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/10/202315:51EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/05/202309:01EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
10/05/202309:00EDGAR2Form DEF 14A - Other definitive proxy statements

Your Recent History

NASDAQ
PCSA
Processa Pharmaceuticals
Delayed Upgrade Clock
ADVFN Logo

Canada
Company
Business
Popular
Get The App

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved